Synthesis of novel 8-substituted carbocyclic analogs of 2',3'-dideoxyadenosine with activity against hepatitis B virus. 2002

Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
Division of Chemistry, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA. kristjan.s.gudmundsson@gsk.com

Synthesis and antiviral activity of several new 8-substituted carbocyclic analogs of D-2',3'-dideoxyadenosine are described. The new 8-substituted analogs were synthesized via lithiation of carbocyclic 2',3'-dideoxyadenosine followed by quenching with electrophiles. This methodology allows for a divergent synthesis of a variety of 8-substituted analogs from carbocyclic 2',3'-dideoxyadenosine in high yields. 8-Methyl and 8-halogenated carbocyclic 2',3'-dideoxyadenosine analogs showed 6-25 fold more activity against hepatitis B virus than the unsubstituted carbocyclic D-2',3'-dideoxyadenosine.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016048 Dideoxyadenosine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite. 2',3'-Dideoxyadenosine,ddA (Antiviral),2',3' Dideoxyadenosine

Related Publications

Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
July 1998, Bioorganic & medicinal chemistry letters,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
May 2000, Organic letters,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
October 2008, Nucleosides, nucleotides & nucleic acids,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
January 2006, Nucleosides, nucleotides & nucleic acids,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
November 2011, Bioorganic & medicinal chemistry letters,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
September 2005, Bioorganic & medicinal chemistry,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
November 1987, Journal of medicinal chemistry,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
April 2022, Chemical biology & drug design,
Kristjan S Gudmundsson, and Susan M Daluge, and Lynn D Condreay, and Lance C Johnson
January 1989, Nucleic acids symposium series,
Copied contents to your clipboard!